newsfilter
← Latest News
Business Wire·

ImmunoGen Announces Collaboration with Takeda to Develop and Commercialize ELAHERE® in Japan

ImmunoGen to Receive $34 Million1 in Upfront and Near-Term Milestone Payments and is Eligible to Receive Potential Regulatory and Commercial Milestone Payments as well as Double-Digit Royalties Collaboration Further